Victoria Pilamunga

[Victoria Pilamunga @VictoriaPilamu2]

@TrendSpider

[Stock Snipa @stocksnipa]

SNOWFLAKE $SNOW REPORTS EARNINGS TODAY AFTER CLOSE

HERE'S EVERYTHING YOU NEED TO KNOW

DATA VIA @EarningsHubHQ

EXPECTING NUMBERS 4:05PM EST

[BioPharm_the_Magnificent @crypto_biotech]

$ARDX Earnings after the bell. My thoughts:

Coiled up after some nice consolidation. It comes down to catalysts to send it to higher and I don’t think it will disappoint .

I expect to see sales of both indications of Tenapanor increase beyond expectations.

That’s great, but not the biggest takeaway I am looking for.

I want to hear plans for Europe & ROW.
(Stay with me here)

They have had ample time to formulate a plan and consider partners, manufacturing, etc. I am hoping they skim it, say they are working on Europe, but they don’t have a solid plan to our ears.

This would be the basis for my buyout thesis. A Europe approval with an Ardelyx sales force would only “muddy” up a buyout from BP as the buyer would want to use their existing assets to maximize the rollout and profit. BO folks want a clean slate for Europe & ROW.

Today is our day. This afternoon won’t come soon enough. Join the CC and listen to one of the most successful c-suites in the last 2 years in Pharma. From Raab’s leadership to Susan (great speaker and who resurrected Ibsrela from the dead ) to the CFO Justin (who has lead buyouts in 2 of his last 3 jobs)- you won’t want to miss this one.

I’ve added in PM and will find a way to load more if we hear a superficial view on progress for Europe. Not investment advice and please do your own DD.

Have a great day everyone!

[Stocktwits @Stocktwits]

Micron stock acting fickle after market close going green to red following a double beat on their report.

Rev: $4.01B vs $3.91B est.
EPS: ($1.07) vs ($1.18) est.

$MU -2% in after hours trading